Cholangiocarcinoma (CCA) is a highly lethal adenocarcinoma of the hepatobiliary system,
which can be classified as intrahepatic, perihilar and distal. Each anatomic subtype has …

Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due
to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular …

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ -
Annals of Oncology Skip to Main Content Advertisement Annals of Oncology European Society …

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …

Introduction Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA)
are the two main histological subtypes of primary liver cancer. Estimates of the burden of …

Cholangiocarcinoma (CCA) is a heterogeneous disease arising from a complex interaction
between host‐specific genetic background and multiple risk factors. Globally, CCA …

Background & Aims Intrahepatic (ICC) and extrahepatic cholangiocarcinoma (ECC) have
rarely been studied individually, probably due to difficulties in their diagnosis and …

Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features
of cholangiocyte differentiation: cholangiocarcinomas are categorized according to …

The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing worldwide. Although
several advances have been made in the past decades to better understand this complex …

Background Intrahepatic cholangiocarcinomas (ICCs) and extrahepatic
cholangiocarcinomas (ECCs) are highly lethal bile duct tumors. Their incidence can be …